DETECTION OF GYRA AND GYRB MUTATIONS IN QUINOLONE-RESISTANT CLINICAL ISOLATES OF ESCHERICHIA-COLI BY SINGLE-STRAND CONFORMATIONAL POLYMORPHISM ANALYSIS AND DETERMINATION OF LEVELS OF RESISTANCE CONFERRED BY 2 DIFFERENT SINGLE GYRA MUTATIONS

被引:57
作者
OUABDESSELAM, S
HOOPER, DC
TANKOVIC, J
SOUSSY, CJ
机构
[1] MASSACHUSETTS GEN HOSP,BOSTON,MA 02114
[2] HARVARD UNIV,SCH MED,BOSTON,MA
关键词
D O I
10.1128/AAC.39.8.1667
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Twelve quinolone-resistant clinical isolates of Escherichia coli (nalidixic acid MICs, 64 to 512 mu g/ml; norfloxacin MICs; 0.25 to 8 mu g/ml) were transformed with plasmid pJSW101 carrying the gyrA(+) gene and with plasmid pJB11 carrying the gyrB(+) gene to examine the proportion of gyrA and gyrB mutations. Transformation with pJSW101 resulted in complementation (nalidixic acid MICs, 4 to 32 mu g/ml; norfloxacin MICs, 0.06 to 0.25 mu g/ml). In contrast, no change in MICs were observed after transformation with pJB11, A 418-bp fragment of gyrA from the 12 strains was amplified by PCR. Direct DNA sequencing of that fragment identified the causes of quinolone resistance in eight strains as a single point mutation leading to a substitution of the serine at position 83 (Ser-83) to Leu and in four strains as a single point mutation leading to a substitution of Asp-87 to Gly. Exchange of the fragment from one of these strains with that of gyrA(+) and transformation of resistance with the hybrid gyrA plasmid indicated the contribution of Gly-87 to resistance and the stabilities of mutants containing GyrA (Gly-87), Thus, gyrA gene mutations are probably encountered more often than gyrB gene mutations in clinical isolates off. coli, In addition, the Substitution of Asp-87 to Gly can be encountered in such strains, On the basis of the level of resistance found in the fragment exchange experiment, the quinolone resistance attributable to Gly-87 appears to be comparable to that attributable to Leu-83, The levels of resistance found in the clinical isolates shown to have a Gly-87 mutation (nalidixic acid MICs, 64 to 512 mu g/ml; norfloxacin MICs, 0.5 to 4 mu g/ml) suggest that the Gly-87 mutation causes resistance at the lei el of the nalidixic acid MIC (64 mu g/ml) or the norfloxacin MIC (0.5 mu g/ml or less) and that the additional increments in resistance seen in the other strains with higher levels of resistance may be attributable to additional mutations, The single-strand conformational polymorphism analysis with PCR products readily detected the Leu 83 and Gly-87 mutations.
引用
收藏
页码:1667 / 1670
页数:4
相关论文
共 26 条
[1]  
AMALIO T, 1993, ANTIMICROB AGENTS CH, V37, P2054
[2]   REPRESSOR MUTATIONS IN THE MARRAB OPERON THAT ACTIVATE OXIDATIVE STRESS GENES AND MULTIPLE ANTIBIOTIC-RESISTANCE IN ESCHERICHIA-COLI [J].
ARIZA, RR ;
COHEN, SP ;
BACHHAWAT, N ;
LEVY, SB ;
DEMPLE, B .
JOURNAL OF BACTERIOLOGY, 1994, 176 (01) :143-148
[3]   CROSS-RESISTANCE TO FLUOROQUINOLONES IN MULTIPLE-ANTIBIOTIC-RESISTANT (MAR) ESCHERICHIA-COLI SELECTED BY TETRACYCLINE OR CHLORAMPHENICOL - DECREASED DRUG ACCUMULATION ASSOCIATED WITH MEMBRANE-CHANGES IN ADDITION TO OMPF REDUCTION [J].
COHEN, SP ;
MCMURRY, LM ;
HOOPER, DC ;
WOLFSON, JS ;
LEVY, SB .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (08) :1318-1325
[4]   CLONING AND CHARACTERIZATION OF A DNA GYRASE-A GENE FROM ESCHERICHIA-COLI THAT CONFERS CLINICAL RESISTANCE TO 4-QUINOLONES [J].
CULLEN, ME ;
WYKE, AW ;
KURODA, R ;
FISHER, LM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (06) :886-894
[5]   HIGH-EFFICIENCY TRANSFORMATION OF ESCHERICHIA-COLI BY HIGH-VOLTAGE ELECTROPORATION [J].
DOWER, WJ ;
MILLER, JF ;
RAGSDALE, CW .
NUCLEIC ACIDS RESEARCH, 1988, 16 (13) :6127-6145
[6]   CIPROFLOXACIN AND THE FLUOROQUINOLONES - NEW CONCEPTS ON THE MECHANISM OF ACTION AND RESISTANCE [J].
FISHER, LM ;
LAWRENCE, JM ;
JOSTY, IC ;
HOPEWELL, R ;
MARGERRISON, EEC ;
CULLEN, ME .
AMERICAN JOURNAL OF MEDICINE, 1989, 87 (5A) :S2-S8
[7]   MUTATIONS IN THE GYRA GENE OF A HIGHLY FLUOROQUINOLONE-RESISTANT CLINICAL ISOLATE OF ESCHERICHIA-COLI [J].
HEISIG, P ;
SCHEDLETZKY, H ;
FALKENSTEINPAUL, H .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (04) :696-701
[8]   MECHANISMS OF QUINOLONE RESISTANCE IN ESCHERICHIA-COLI - CHARACTERIZATION OF NFXB AND CFXB, 2 MUTANT RESISTANCE LOCI DECREASING NORFLOXACIN ACCUMULATION [J].
HOOPER, DC ;
WOLFSON, JS ;
SOUZA, KS ;
NG, EY ;
MCHUGH, GL ;
SWARTZ, MN .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (03) :283-290
[9]   GENETIC AND BIOCHEMICAL-CHARACTERIZATION OF NORFLOXACIN RESISTANCE IN ESCHERICHIA-COLI [J].
HOOPER, DC ;
WOLFSON, JS ;
SOUZA, KS ;
TUNG, C ;
MCHUGH, GL ;
SWARTZ, MN .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 29 (04) :639-644
[10]   GENETICS AND REGULATION OF OUTER-MEMBRANE PROTEIN EXPRESSION BY QUINOLONE RESISTANCE LOCI NFXB, NFXC, AND CFXB [J].
HOOPER, DC ;
WOLFSON, JS ;
BOZZA, MA ;
NG, EY .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (05) :1151-1154